Publication:
Tumor cell-specific inhibition of inducible nitric oxide synthase activation by tiazofurin

dc.contributor.authorSamardzic, Tatjana (6602855000)
dc.contributor.authorStosic-Grujicic, Stanislava (7004253020)
dc.contributor.authorRaicevic, Nevena (35333437200)
dc.contributor.authorTrajkovic, Vladimir (7004516866)
dc.date.accessioned2025-06-13T00:49:30Z
dc.date.available2025-06-13T00:49:30Z
dc.date.issued2001
dc.description.abstractThe effects of tiazofurin (TR) on proliferation and cytokine-induced nitric oxide (NO) production in the L929 fibrosarcoma cell line and murine embryonic fibroblasts were investigated. Treatment with TR inhibited the growth of nonconfluent L929 cells in a dose-dependent manner. TR, at concentrations not affecting cell viability or proliferation, markedly decreased IFN-γ + LPS-induced expression of inducible NO synthase (iNOS) mRNA and, subsequently, NO production in confluent L929 cultures. However, TR did not interfere with the IFN-γ-triggered expression of mRNA for IRF-1, an important iNOS transcription factor, implying that TR interferes with some other intracellular pathway involved in iNOS induction triggered by IFN-γ + LPS. In contrast to the results obtained in L929 cells, iNOS mRNA expression induced by IFN-γ + LPS in murine embryonic fibroblasts was resistant to TR, indicating a tumor-selective action of this agent. © 2001 Elsevier Science B.V.
dc.identifier.urihttps://doi.org/10.1016/S1567-5769(01)00014-5
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0035103116&doi=10.1016%2fS1567-5769%2801%2900014-5&partnerID=40&md5=74c388a483d43947412ebfbec986b942
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/11272
dc.subjectFibroblast
dc.subjectNitric oxide
dc.subjectTiazofurin
dc.subjectTumor
dc.titleTumor cell-specific inhibition of inducible nitric oxide synthase activation by tiazofurin
dspace.entity.typePublication

Files